Development and use of a method based on the anti-N reactivity of longitudinal samples to better estimate SARS-CoV-2 seroprevalence in a vaccinated population

Renée Bazin, Samuel Rochette, Josée Perreault, Marie-Josée Fournier, Yves Grégoire, Amélie Boivin, Antoine Lewin, Marc Germain, Christian Renaud
doi: https://doi.org/10.1101/2022.08.15.22278798

Article usage

Article usage: August 2022 to January 2025

AbstractFullPdf
Aug 20225881199
Sep 2022120321
Oct 20226213
Nov 20226314
Dec 20225226
Jan 20233953
Feb 20231913
Mar 20233133
Apr 20232218
May 20232025
Jun 2023941
Jul 20231014
Aug 202322104
Sep 20231343
Oct 20231030
Nov 202333253
Dec 2023902
Jan 2024902
Feb 20241324
Mar 2024738
Apr 2024832
May 2024715
Jun 20241227
Jul 2024818
Aug 20241547
Sep 20243125
Oct 20241069
Nov 20241516
Dec 2024509
Jan 2025502
Back to top
Posted August 18, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Development and use of a method based on the anti-N reactivity of longitudinal samples to better estimate SARS-CoV-2 seroprevalence in a vaccinated population
Renée Bazin, Samuel Rochette, Josée Perreault, Marie-Josée Fournier, Yves Grégoire, Amélie Boivin, Antoine Lewin, Marc Germain, Christian Renaud
medRxiv 2022.08.15.22278798; doi: https://doi.org/10.1101/2022.08.15.22278798
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area